Quantum BioPharma Ltd. Adjustments For Fair Value Gains Losses
Quantum BioPharma Ltd. (QNTM) reported Adjustments For Fair Value Gains Losses of $234.23 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-31.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForFairValueGainsLosses · last filed 2023-03-31
CAD
| Period end | Adjustments For Fair Value Gains Losses 12 month |
|---|---|
| 2019-12-31 | 11.67M CAD 40-F/A · filed 2020-03-17 |
| 2018-12-31 | -17.56M CAD 40-F/A · filed 2020-03-17 |
USD
| Period end | Adjustments For Fair Value Gains Losses 12 month |
|---|---|
| 2022-12-31 | $234.23K 20-F · filed 2023-03-31 |
| 2021-12-31 | $858.48K 20-F · filed 2023-03-31 |
| 2020-12-31 | $770.87K 20-F · filed 2023-03-31 |
| 2019-12-31 | $8.78M 40-F · filed 2021-03-17 |